For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Theraclone Sciences, Inc.

USPTO Granted Patents = 28

% Expired Patents = 46.4

EPO Patents = 9

Forward Citations = 76

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Ole Olsen (24 out of 35 patents)

Matthew Moyle (22 out of 32 patents)

Jennifer L Mitcham (22 out of 60 patents)

4. Po-Ying Chan-Hui (16 out of 27 patents)

5. Steven Frey (15 out of 21 patents)

6. Sanjay K Phogat (14 out of 25 patents)

7. Dennis R Burton (14 out of 55 patents)

8. Pascal Raymond Georges Poignard (14 out of 16 patents)

9. Melissa Danielle De Jean De St Marcel Simek-Lemos (14 out of 14 patents)

10. Wayne C Koff (14 out of 25 patents)

11. Stephen Kaminsky (13 out of 19 patents)

12. Laura Marjorie Walker (10 out of 10 patents)

13. Andres G Grandea, Iii (8 out of 8 patents)

14. Thomas C Cox (7 out of 7 patents)

15. Katherine Doores (6 out of 6 patents)

28 patents: Sort by Forward Citations

1. 12410243 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2025-09-09),

2. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2025-05-27),

3. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2024-06-25),

4. 11845789 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2023-12-19),

5. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2023-02-21),

6. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2022-05-03),

7. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2020-12-15),

8. 10836811 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2020-11-17),

9. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-09-10),

10. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-03-26),

11. 10087239 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2018-10-02),

12. 9920111 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2018-03-20),

13. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2016-10-11),

14. 9051362 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2015-06-09),

15. 8974788 - Compositions and methods for the therapy and diagnosis of influenza (2015-03-10),

Theraclone Sciences, Inc. is a biotechnology company focused on discovering and developing novel therapeutic antibodies. With expertise in immune repertoire analysis and the isolation of rare, potent antibodies, Theraclone aims to address unmet medical needs and improve patient outcomes. Their innovative approach incorporates the use of cutting-edge technologies and deep understanding of the immune system to develop antibody-based therapeutics for various diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

28 Patents

#81 in Seattle, WA

#271 in Washington

#11,985 in US

#23,212 in the World

Seattle, WA, United States of America

Theraclone Sciences, Inc.

Forward Citations = 76

20 inventors:

Ole Olsen (24 out of 35 patents)

Matthew Moyle (22 out of 32 patents)

Jennifer L Mitcham (22 out of 60 patents)

4. Po-Ying Chan-Hui (16 out of 27 patents)

5. Steven Frey (15 out of 21 patents)

Please report any incorrect information to [email protected]

Loading…